Skip to main content
. 2016 Jul 23;7(39):64400–64409. doi: 10.18632/oncotarget.10794

Figure 3. Kaplan-Meier analysis of overall survival of patients with disease control (solid line; n = 155) and with progressive disease (dotted line; n = 141).

Figure 3

Median survival time was 14.9 months vs. 7.6 months, respectively (p < 0.0001).